THE PHARMASEUTICAL COMPOSITIONS FOR PREVENTION OR TREATMENT OF HEPATITIS B CONTAINING CINNAMOMUM EXTRACTS, ITS FRACTIONS, OR TRANS-CINNAMALDEHYDE OR 2-METHOXYCINNAMALDEHYDE ISOLATED FROM CINNAMOMUM AS AN ACTIVE INGREDIENT

摘要

PURPOSE: A pharmaceutical composition containing a cinnamon extract, a fraction thereof, or trans-cinnamaldehyde or 2-methoxycinnamaldehyde isolated from cinnamon for preventing and treating hepatitis type B is provided to suppress the generation of hepatitis B virus e antigen and s antigen. CONSTITUTION: A pharmaceutical composition for preventing and treating hepatitis type B contains trans-cinnamaldehyde or 2-methoxycinnamaldehyde, which is isolated from cinnamon, as an active ingredient. A cinnamon extract is prepared using water, alcohol, or a mixture thereof. [Reference numerals] (AA) Suppression rate(%); (BB) Treatment concentration(uM);